Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 29.80
+1.00 (3.47%)
Mar 24, 2026, 1:30 PM CST
Apex Biotechnology Revenue
In the year 2025, Apex Biotechnology had annual revenue of 1.94B TWD with 5.00% growth. Apex Biotechnology had revenue of 438.99M in the quarter ending December 31, 2025, a decrease of -3.30%.
Revenue
1.94B
Revenue Growth
+5.00%
P/S Ratio
1.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.94B | 92.70M | 5.00% |
| Dec 31, 2024 | 1.85B | 175.67M | 10.48% |
| Dec 31, 2023 | 1.68B | -567.64M | -25.29% |
| Dec 31, 2022 | 2.24B | 112.52M | 5.28% |
| Dec 31, 2021 | 2.13B | 126.32M | 6.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.14B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Synbio Tech | 1.04B |
| Genovate Biotechnology | 492.41M |
| 3D Global Biotech | 324.87M |
| HeXun Biosciences | 290.83M |
| Intech Biopharm | 113.85M |
| GlycoNex Incorporation | 37.86M |